07.01.2013 Views

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

F5HAR<br />

57333<br />

HIAA<br />

9248<br />

can also be administered intravenously (available outside of the United States). There is good correlation<br />

between serum concentrations of flucytosine with both efficacy and risk for toxicity. Because of the<br />

drugâ€s short half-life (3-6 hours), therapeutic monitoring is typically performed at peak levels, 1 to 2<br />

hours after an oral dose or 30 minutes after intravenous administration. Flucytosine is eliminated<br />

primarily as unmetabolized drug in urine. Patients with renal dysfunction may require dose adjustments or<br />

more frequent monitoring to ensure that serum concentrations do not accumulate to excessive levels.<br />

Nephrotoxicity associated with use of amphotericin B can affect elimination of flucytosine when the<br />

drugs are coadministered.<br />

Useful For: Monitoring serum concentration during therapy Evaluating potential toxicity The test may<br />

also be useful to evaluate patient compliance<br />

Interpretation: Most individuals display optimal response to flucytosine when peak serum levels (1-2<br />

hours after oral dosing) are >25.0 mcg/mL. Some infections may require higher concentrations for<br />

efficacy. Toxicity is more likely when peak serum concentrations are >100.0 mcg/mL.<br />

Reference Values:<br />

Therapeutic concentration:<br />

Peak >25.0 mcg/mL (difficult infections may require higher concentrations)<br />

Toxic concentration:<br />

Peak >100.0 mcg/mL<br />

Clinical References: 1. Goodwin ML, Drew RH: Antifungal serum concentration monitoring: an<br />

update. J Antimicrobial Chemotherapy 2008;61:17-25 2. Andes D, Pascual A, Marchetti O: Antifungal<br />

therapeutic drug monitoring: established and emerging indications. Antimicrobial Agents Chemotherapy<br />

2009;53(1):24-34<br />

5-HIAA (5-Hydroxyindoleacetic Acid), Random Urine<br />

Reference Values:<br />

5-HIAA mg/g creat<br />

2-10 YRS: 12.0 or less<br />

>10 YRS: 10.0 or less<br />

Creatinine, Random Urine mg/dL<br />

Age mg/dL<br />

0-6 Months 2-32<br />

7-11 Months 2-36<br />

1-2 Years 2-128<br />

3-8 Years 2-149<br />

9-12 Years 2-183<br />

>12 Years<br />

Males: 20-370<br />

Females: 20-320<br />

<strong>Test</strong> Performed by: Quest Diagnostics Nichols Institute<br />

33608 Ortega Highway<br />

San Juan Capistrano, CA 92690-6130<br />

5-Hydroxyindoleacetic Acid (5-HIAA), Urine<br />

Clinical Information: Normally 1% to 3% of dietary tryptophan is metabolized to serotonin.<br />

However, as much as 50% of tryptophan is converted to serotonin in patients with the intestinal carcinoid<br />

syndrome. 5-Hydroxyindoleacetic acid (5-HIAA) is the major metabolite of serotonin and is excreted in<br />

the urine. Measurement of 5-HIAA in a 24-hour urine specimen can diagnose carcinoid disease with a<br />

high specificity.<br />

Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong><strong>Laboratories</strong>.com Page 34

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!